Straits Times Index
3,297.55 -26.98 (-0.81%) S&P 500
5,431.60 -2.14 (-0.04%) Dow
38,589.16 -57.94 (-0.15%) Nasdaq
17,688.88 +21.28 (+0.12%) Bitcoin USD
66,264.55 +208.44 (+0.32%) CMC Crypto 200
1,403.43 -14.44 (-1.02%)
BioRem Inc. (BIRMF)
| Previous close | 1.4200 |
| Open | 1.4200 |
| Bid | 0.0005 x 0 |
| Ask | 1.4300 x 0 |
| Day's range | 1.4200 - 1.4200 |
| 52-week range | 0.6700 - 1.5000 |
| Volume | |
| Avg. volume | 3,690 |
| Market cap | 22.29M |
| Beta (5Y monthly) | 0.88 |
| PE ratio (TTM) | 10.92 |
| EPS (TTM) | 0.1300 |
| Earnings date | 21 Aug 2024 - 26 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
CNW GroupBiorem Announces Stock Option Grant
Biorem Inc. (TSXV:BRM)("Biorem", or "the Company") announces that, pursuant to its incentive Stock Option Plan, it has granted incentive stock options to certain directors of the Company to purchase up to an aggregate of 50,000 common shares in the capital stock of the Company. The options are exercisable at a price of $1.96 per share for a period of ten years from the date of grant.
CNW GroupBIOREM Reports Strong First Quarter Financial Results and Continued Growth in Order Backlog
BIOREM Inc. (TSXV: BRM) ("BIOREM" or "the Company") today announced results for the three month period ended March 31, 2024. BIOREM's complete 2024 first quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
CNW GroupBiorem Reports 2023 Financial Results including $0.14 earnings per share
BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2023. Biorem's complete fiscal 2023 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com).
